View a stock's price,volume,volatility and other statistics,as well as a price chart,news,performance vs.peers and a company profile.Immunitybio Inc. The Company is engaged in developing molecular and product platforms based on three key modalities activating NK and T cells using antibody cytokine fusion proteins,activating Something is wrong.Please try again.See more on MSN Data from Refinitiv Price in USD Market closed DisclaimerNantKwest,Inc.(NK) Stock Price,News,Quote History NantKwest,Inc.(NASDAQ NK),a clinical-stage,natural killer cell-based therapeutics company,today announced that its stockholders approved by the required vote each of the proposals related toRelated searches for NK A stocknk stock forecastnk stock analysisnk stock price targetnk stock discussionnk stock forumnews on nk stocknk stock news pancreatic cancernk stock chartSome results are removed in response to a notice of local law requirement.For more information,please see here.Previous123456Next
nk stock forecastnk stock analysisnk stock price targetnk stock discussionnk stock forumnews on nk stocknk stock news pancreatic cancernk stock chartSome results are removed in response to a notice of local law requirement.For more information,please see here.12345NextNantKwest,Inc.(NK) Stock Quotes NasdaqNantKwest,Inc.(NK) Stock Quotes - Nasdaq offers stock quotes market activity data for US and global markets.NantKwest,Inc.(NK) Stock Quotes NasdaqNantKwest,Inc.(NK) Stock Quotes - Nasdaq offers stock quotes market activity data for US and global markets.NantKwest,Inc.(NK) Stock A Biotech Stock Thats Seeing Jul 27,2019 NK A stock#0183;This Year So Far Since the open of this year NK has resulted in a return of 8.62%.Annually Lastly,over the past full year,investors have seen movement amounting to -64.41% from NK.Over this period,the stock has traded at a high of -70.21% and a low price of 35.48%.Ratios Of Note
NantKwest,Inc.(NK) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets.NantKwest,Inc.(NK) Pre-Market Quotes NasdaqNantKwest,Inc.(NK) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets.NantKwest,Inc.(NASDAQ:NK) It Is A Stock Worth Jan 19,2021 NK A stock#0183;Although NK has showed a red trend with a performance of -3.04% at the end of last trading.The performance over the last five days has remained in the green territory.The rise to weekly highs of $20.05 on Thursday,Jan 14 increased the stocks daily price by 13.97%.
NantKwest currently has 1 buy rating from Wall Street analysts.The stock has a consensus analyst rating of Buy. A buy rating indicates that analysts believe NK will outperform the market and that investors should add to their positions of NantKwest.View the latest ratings for NK.NantKwest Stock Investment (NASDAQ:NK) - MacroaxisThe NantKwest probability density function shows the probability of NantKwest stock to fall within a particular range of prices over 30 days.Allowing for the 30-day total investment horizon the stock has a beta coefficient of 1.4282.This indicates as the benchmark fluctuates upward,the company is expected to outperform it on average.NantKwest Stock Forecast up to 55.810 USD! - NK Stock NantKwest Inc () Stock Market info Recommendations Buy or sell NantKwest stock? Wall Street Stock Market Finance report,prediction for the future You'll find the NantKwest share forecasts,stock quote and buy / sell signals below.According to present data NantKwest's NK shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists).
Feb 16,2021 NK A stock#0183;The average equity rating for NK stock is currently 2.00,trading closer to a bullish pattern in the stock market.The market cap for the stock reached $2.84 billion,with 108.25 million shares outstanding and 35.19 million shares in the current float.NantKwest Inc - NK - Stock forecast - 3 months stock price In the short term (2weeks),NK's stock price should outperform the market by 2.41%.During that period the price should oscillate between -11.87% and +14.56%.In the medium term (3months),NK's stock price should underperform the market by -8.03%.During that period the price should oscillate between -39.45% and +30.07%.NantKwest Inc (NK) Stock Analysis - XNAS MorningstarFind out if NK (XNAS) is the best investment for you.Start a 14-day free trial to Morningstar Premium to unlock our take on NK.
Stock analysis for Imerys SA (NK:EN Paris) including stock price,stock chart,company news,key statistics,fundamentals and company profile.NK Stock Price,NantKwest Stock Quotes and News - BenzingaFeb 23,2021 NK A stock#0183;NantKwest (NantKwest NK) stock research,analysis,profile,news,analyst ratings,key statistics,fundamentals,stock price,charts,earnings,guidance and peers.NK Stock Price Increases Over 15% Pre-Market Why ItMar 09,2021 NK A stock#0183;The stock price of Nantkwest Inc (NASDAQ NK) increased by over 15% pre-market.This is why it happened.The stock price of Nantkwest Inc (NASDAQ NK) a clinical-stage,natural killer cell-based therapeutics company increased by over 15% pre
Jan 27,2021 NK A stock#0183;NK Complete Imerys stock news by MarketWatch.View real-time stock prices and stock quotes for a full financial overview.NK Stock News - FidelityJan 20,2021 NK A stock#0183;NantKwest (NK) and ImmunityBio s QUILT 88 Trial Shows Novel Combination Immunotherapy,Which Includes Aldoxorubicin,Has More Than Doubled Historic Median Survival Rates in Patients CytRx Corporation (CYTR),a specialized biopharmaceutical company focused on research and development for the oncology and neurodegenerative disease categories NK Stock NANTKWEST Stock Price Today Markets InsiderMar 09,2021 NK A stock#0183;NK Get the latest NantKwest stock price and detailed information including NK news,historical charts and realtime prices.
NK stock was sold by a variety of institutional investors in the last quarter,including Dimensional Fund Advisors LP,Dimensional Fund Advisors LP,Barclays PLC,Creative Planning,ETF Managers Group LLC,Alliancebernstein L.P.,State of Wisconsin Investment Board,and Charles Schwab Investment Management Inc..NK Seeds Syngenta USIn 2019,we opened our trait introgression facility as a $30 million investment toward bringing you NK hybrids and varieties faster than ever before.And with our gene-editing technology we make sure every product performs to your standards.Instant Tailored Placement.Our Seed Analyzer tool is a realization of everything we stand for at NK.NK NantKwest,Inc.Stock Quote - FINVIZIs NK A Good Stock To Buy Now? Insider Monkey +7.69%.09:48PM The company develops activated natural killer (aNK) cell,a natural killer cell-line and genetically modified derivative capable of killing cancer and virally infected cells; and Nant cancer vaccine,a personalized therapy that utilizes its off-the-shelf natural killer cells.
NantKwest Inc.options quotes data for sells and puts,including NK last price,change and volume.Dow Jones,a News Corp company. Stock Movers Gainers,decliners and most actives market NK NantKwest Inc.Analyst Estimates MarketWatchFeb 02,2021 NK A stock#0183;NantKwest Inc.analyst estimates,including NK earnings per share estimates and analyst recommendations.NK Conversations From StockTwits - POWR Stock Rating Mar 03,2021 NK A stock#0183;We have 9 different ratings for every stock to help you appreciate its future potential.You can unlock it all now.Just click the link above.
ImmunityBio,Inc.and NantKwest,Inc.(NASDAQ NK),today announced the completion of their previously announced 100% stock-for-stock merger.This follows the satisfaction of all customary closing conditions,including approval of the merger by a majority of unaffiliated shareholders of NantKwest at its Special Meeting held on March 8,2021.NK - Nantkwest CS Stock Profile - Barchart60-Month Beta Coefficient that measures the volatility of a stock's returns relative to the market (SP 500).It is based on a 60-month historical regression of the return on the stock onto the return on the SP 500.% of Institutional Shareholders The percent of ownership held byNK - Nantkwest CS Stock Price - BarchartImmunityBio,Inc.and NantKwest,Inc.(NASDAQ NK),today announced the completion of their previously announced 100% stock-for-stock merger.This
NK,$NK,NantKwest Inc stock technical analysis with charts,breakout and price targets,support and resistance levels,and more trend analysis indicatorsMedium Cap Stock NantKwest,Inc.(NK) is a Buy Analysts Feb 08,2021 NK A stock#0183;The consensus among analysts is that NantKwest,Inc.(NK) is a Buy stock at the moment,with a recommendation rating of 2.None of the analysts rate the stock as a Sell,while none rate it as Overweight.None out of 1 have rated it as a Hold,with 1 advising it as a Buy.None have rated the stock as Underweight.MSNMSN
Nantkwest Inc (NK) stock is trading at $34.81 as of 1:43 PM on Tuesday,Feb 23,a loss of -$7.44,or -17.62% from the previous closing price of $42.25.The stock has traded between $32.37 and $41.41 so far today.Volume today is more active than usual.So far 2,259,484 shares have traded compared to average volume of 1,525,598 shares.Is NantKwest Stock a good buy NASDAQ:NK - MacroaxisA single investing idea is a collection of funds,stocks,ETFs,or cryptocurrencies that are programmatically selected from a pull of investment themes.After you determine your investment opportunity,you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Is NK A Good Stock To Buy Now? - YahooDec 11,2020 NK A stock#0183;Do Hedge Funds Think NK Is A Good Stock To Buy Now? At Q3's end,a total of 10 of the hedge funds tracked by Insider Monkey were long this stock,a
Dec 10,2020 NK A stock#0183;Nantkwest Inc (NASDAQ NK) was in 10 hedge funds portfolios at the end of the third quarter of 2020.The all time high for this statistics is 8.This means the bullish number of hedge fundImmunityBio (IBRX) Stock Price,Quote News Stock AnalysisMar 17,2021 NK A stock#0183;Natural killer (or NK) cancer therapies are hot right now.Here are two stocks that are early leaders in the field -- one is a buy,and the other one is not. (NK) stock based on the movements in the options market lately.Other stocks mentioned NK.1 year ago - Zacks Investment Research.Here's a Cancer-Killing Stock to Buy for 2021 The Motley Dec 30,2020 NK A stock#0183;Here's a Cancer-Killing Stock to Buy for 2021 Natural killer (or NK) cancer therapies are hot right now.Here are two stocks that are early leaders in the field --
Stock analysis for ImmunityBio Inc (NK) including stock price,stock chart,company news,key statistics,fundamentals and company profile.Earnings report expected on March 24ZacksImmunitybio IncNASDAQ IBRXOVERVIEWFINANCIALS35.53 NK A stock#9650; 1.17 (3.41%)35.530.00(0.00%)After Hours March 19, 7:55 PM EDTDayWeekMonthYear5 YearMaxThis chart isnt available.LoadingOpen34.70P/E-Vol3.15 MHigh35.8452wk High45.42Avg Vol1.49 MLow33.5552wk Low2.52Mkt Cap13.61 B
Mar 12,2021 NK A stock#0183;The ETF Stock Finder Tool helps you find an ETF's allocation to a certain stock.The tool is limited to U.S NK A stockmon equities listed on U.S.stock exchanges.Author Taylor CarmichaelNK Price Target,Analyst Ratings and Predictions (NantKwest)Jun 03,2020 NK A stock#0183;Their average twelve-month price target is $18.00,predicting that the stock has a possible downside of 47.61%.The high price target for NK is $18.00 and the low price target for NK is $18.00.There are currently 1 buy rating for the stock,resulting in a consensus rating of Buy.Author Debasis SahaShould I buy (NK) - ZacksMar 09,2021 NK A stock#0183;Zacks' proprietary data indicates that NantKwest,Inc.is currently rated as a Zacks Rank 3 and we are looking for an inline return from the NK shares relative to the market in the next few months.
Is the Options Market Predicting a Spike in NantKwest (NK) Stock? by Zacks Equity Research Published on January 10,2019 .Investors need to pay close attention to NantKwest (NK) stock based on the All News for NK NantKwest,Inc.- ZacksIs the Options Market Predicting a Spike in NantKwest (NK) Stock? by Zacks Equity Research Published on January 10,2019 .Investors need to pay close attention to NantKwest (NK) stock based on the results for this questionWho are the insiders that sell NantKwest stock?Who are the insiders that sell NantKwest stock?NK stock was sold by a variety of institutional investors in the last quarter,including Creative Planning.Company insiders that have sold NantKwest company stock in the last year include Barry J Simon,Frederick W Driscoll,John C Thomas,and Sonja Nelson.NK Stock Forecast,Price News (NantKwest) MarketBeat
The NantKwest stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock.Also,there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. results for this questionAre there any stocks similar to NantKwest Inc?Are there any stocks similar to NantKwest Inc?Stocks with similar financial metrics,market capitalization,and price volatility to NantKwest Inc are CYAD,AUPH,BLU,PRKR,and PSTI.Visit NK's SEC page to see the company's official filings.NK -- Is Its Stock Price A Worthy Investment? Learn More.